TriMas (NASDAQ:TRS - Get Free Report) is expected to be posting its Q2 2025 quarterly earnings results before the market opens on Tuesday, July 29th. Analysts expect TriMas to post earnings of $0.50 per share and revenue of $251.18 million for the quarter. TriMas has set its FY 2025 guidance at 1.700-1.850 EPS.
TriMas (NASDAQ:TRS - Get Free Report) last released its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. TriMas had a net margin of 3.36% and a return on equity of 10.54%. The firm had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. During the same period in the prior year, the firm earned $0.37 earnings per share. The business's quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts expect TriMas to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
TriMas Stock Down 0.3%
Shares of TRS stock traded down $0.10 during trading hours on Friday, reaching $31.43. 325,765 shares of the stock were exchanged, compared to its average volume of 357,893. The business's fifty day moving average is $28.06 and its two-hundred day moving average is $24.88. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.82 and a quick ratio of 1.49. TriMas has a 12-month low of $19.33 and a 12-month high of $31.77. The firm has a market capitalization of $1.28 billion, a P/E ratio of 40.82 and a beta of 0.63.
TriMas Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 12th. Shareholders of record on Tuesday, August 5th will be paid a $0.04 dividend. The ex-dividend date of this dividend is Tuesday, August 5th. This represents a $0.16 annualized dividend and a yield of 0.51%. TriMas's dividend payout ratio is currently 20.78%.
Insider Activity at TriMas
In related news, Director Shawn Sedaghat purchased 410,172 shares of the company's stock in a transaction on Wednesday, May 21st. The shares were bought at an average cost of $25.43 per share, for a total transaction of $10,430,673.96. Following the completion of the purchase, the director directly owned 1,810,821 shares of the company's stock, valued at approximately $46,049,178.03. This trade represents a 29.28% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Adrianne Shapira acquired 4,000 shares of the firm's stock in a transaction dated Thursday, June 5th. The stock was purchased at an average cost of $25.82 per share, with a total value of $103,280.00. Following the completion of the acquisition, the director directly owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 971,649 shares of company stock worth $24,585,343 over the last quarter. 14.20% of the stock is currently owned by insiders.
Institutional Investors Weigh In On TriMas
A hedge fund recently raised its stake in TriMas stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of TriMas Corporation (NASDAQ:TRS - Free Report) by 4.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,120 shares of the industrial products company's stock after purchasing an additional 1,014 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of TriMas worth $565,000 as of its most recent SEC filing. Institutional investors and hedge funds own 99.42% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on TRS. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. BWS Financial reiterated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Wednesday, April 30th.
Check Out Our Latest Stock Analysis on TriMas
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.